Humoral responses against the C-terminal region of merozoite surface protein 1 can be remembered for more than 30 years in persons exposed to Plasmodium vivax

Parasitology Research

Volumn 92, Issue 5, 2004, Pages 384-389

  Lim, Kook Jin ^a   Park, Jea Won ^b   Yeom, Joon Sup ^c   Lee, Young Ha ^d   Yoo, Seung Bum ^e   Oh, Jae Hoon ^e   Sohn, Mi Jin ^e   Bahk, Young Yil ^a   Kim, Yu Sam ^a  

^a Yonsei University   (South Korea)

^b Gachon University   (South Korea)

^c Sungkyunkwan University School of Medicine   (South Korea)

^d Chungnam National University   (South Korea)

^e LGCI   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

MALARIA VACCINE; MEMBRANE PROTEIN;

ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CARBOXY TERMINAL SEQUENCE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMORAL IMMUNITY; IMMUNOLOGICAL MEMORY; IMMUNOPROPHYLAXIS; INFECTION PREVENTION; MALARIA; MALE; MEROZOITE; NONHUMAN; PLASMODIUM VIVAX; PREVALENCE; PRIORITY JOURNAL; RECURRENT DISEASE; SERUM; VACCINATION;

ADOLESCENT; ADULT; AGED; ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; CHILD; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOLOGIC MEMORY; MALARIA, VIVAX; MALE; MEROZOITE SURFACE PROTEIN 1; MIDDLE AGED; PLASMODIUM VIVAX; PROTOZOAN PROTEINS; TIME FACTORS;

PLASMODIUM VIVAX;

EID: 1842789762     PISSN: 09320113     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00436-003-1009-0     Document Type: Article

References (32)

1. Alves FP, Durlacher RR, Menezes MJ, Krieger H, Silva LH, Camargo EP (2002) High prevalence of asymptomatic Plasmodium vivax and Plasmodium falciparum infection in native Amazonian populations. Am J Trop Med Hyg 66:641-648
2. Blackman MJ, Heidrich HG, Donachie S, McBride JS, Holder AA (1990) A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion blocking antibodies. J Exp Med 172:379-382
3. Blackman MJ, Scott-Finnigan TJ, Shai S, Holder AA (1994) Antibodies inhibit the protease-mediated processing of a malaria merozoite surface protein. J Exp Med 180:389-393
4. Bruce MC, Donnelly CA, Packer M, Lagog M, Gibson N, Narara A, Walliker D, Alpers MP, Day KP (2000) Age- and species-specific duration of infection in asymptomatic malaria infection in Papua New guinea. Parasitology 121:247-256
5. Chitarra V, Holm I, Bentley G, Petres S, Longacre S (1999) The crystal structure of C-terminal merozoite surface protein 1 at 1.8 Å resolution, a highly protective malaria vaccine candidate. Mol Cell 3:457-464
6. Coleman RE, Maneechai N, Rachapaew N, Kumpitak C, Soyseng V, Miller RS, Thimasarn K, Sattabongkot J (2002) Field evaluation of the ICT Malaria Pf/Pv immunochromatographic test for the detection of asymptomatic malaria in a Plasmodium falciparum/vivax endemic area in Thailand. Am J Trop Med Hyg 66:379-383
7. 19) of Plasmodium vivax in Saimiri boliviensis monkeys. Am J Trop Med Hyg 60:350-356
8. Egan AF, Morris J, Barnish G, Allen S, Greenwood BM, Kaslow DC, Holder AA, Riley EM (1996) Clinical immunity to Plasmodium falciparum malaria is associated with serum antibodies to the 19-kDa C-terminal fragment of the merozoite surface antigen, PfMSP-1. J Infect Dis 173: 765-769
9. Greenwood BM, Marsh K, Snow RW (1991) Why do some African children develop severe malaria? Parasitol Today 7: 277-281
10. Hirunpetcharat C, Vukovic P, Liu XQ, Kaslow DC, Miller LH, Good MF (1999). Absolute requirement for an active immune response involving B cells and Th cells in immunity to Plasmodium yoelii passively acquired with antibodies to 19-kDa carboxyl-terminal fragment of merozoite surface protein-1. J Immunol 162:7309-7314
11. 19, secreted from Saccharomyces cerevisiae. Immunol Lett 51:187-189
12. Kim DC (1982) Status of malaria infection in the Republic of Korea. Yonsei Rep Trop Med 13:59-62
13. Kooyman FN, Yatsuda AP, Ploeger HW, Eysker M (2002) Serum immunoglobulin E response in calves infected with the lung-worm Dictyocaulus viviparus and its correlation with protection. Parasite Immunol 2447-56
14. Kwiatkowski D, Nowak M (1991) Periodic and chaotic host-parasite interactions in human malaria. Proc Natl Acad Sci USA 88:5111-5113
15. Lee HK, Lim J, Lee S, Oh EJ, Lee J, Oh J, Kim Y, Han K, Lee EJ, Kang CS, Kim BK (2001) Immunological alterations associated with Plasmodium vivax malaria in South Korea. Ann Trop Med Parasitol 95:31-39
16. Lim KJ, Park JW, Sohn MJ, Lee S, Oh JH, Kim HC, Bahk YY, Kim YS (2002) A direct sandwich ELISA to detect antibodies against the C-terminal region of merozoite surface protein 1 could be a useful diagnostic method to identify Plasmodium vivax exposed persons. Parasitol Res 88:855-860
17. Long HY, Lell B, Dietz K, Kremsner PG (2001) Plasmodium falciparum: in vitro growth inhibition by febrile temperature. Parasitol Res 87:553-555
18. Mamoni RL, Rossi CL, Camargo ZP, Blotta HSL (2001) Capture enzyme-linked immunosorbent assay to detect specific immunoglobulin E in sera of patients with paracoccidioidomycosis. Am J Trop Med Hyg 65:237-241
19. 19 across distantly related Plasmodium species. Nat Med 6:91-95
20. 19 are a major component of the invasion-inhibitory response in individuals immune to malaria. J Exp Med 193:1403-1412
21. Park JW, Moon SH, Yeom JS, Lim KJ, Sohn MJ, Jung WC, Cho YJ, Jeon KW, Ju W, Ki CS, Oh MD, Che KW (2001) Naturally acquired antibody response to the C-terminal region of merozoite surface protein 1 of Plasmodium vivax in Korea. Clin Diagn Lab Immunol 8:14-20
22. Perlmann P, Perlmann H, ElGhazali G, Blomberg MT (1999) IgE and tumor necrosis factor in malaria infection. Immunol Lett 65:29-33
23. Perisidis A (2000) Malaria. Nat Biotechnol 18:111-112
24. Ree HI (1998) Can malaria be endemic in South Korea? Korean J Infect Dis 30:397-400
25. Richie TL, Saul A (2002) Progress and challenges for malaria vaccines. Nature 415:694-701
26. Shi YP, Sayed U, Qari SH, Roberts JA, Udhayakumar V, Oloo AJ, Hawley WA, Caslow DC, Nahlen BL, Lal AA (1996) Natural immune response to C-terminal 19-kilodalton domain of Plasmodium falciparum merozoite surface protein 1. Infect Immun 64:2716-2723
27. Snounou GS, Viriyakosol S, Zhu XP, Jarra W, Pinheiro L, Rosario VE, Thaithong S, Brown KN (1993) High sensitivity of detection of human malaria parasites by the use of nest polymerase chain reaction. Mol Biochem Parasitol 61:315-320
28. Soares IS, Levitus G, Souza JM, Portillo HAD, Rodrigues MM (1997) Acquired immune response to N-and C-terminal region of Plasmodium vivax merozoite surface protein 1 in individuals exposed to malaria. Infect Immun 65:1606-1614
29. Soares IS, Maristela GDC, Silva MN, Souza JM, Portillo HAD, Rodrigues MM (1999) Longevity of naturally acquired antibody response to the N-and C-terminal regions of Plasmodium vivax merozoite surface protein 1. Am J Med Hyg 60:357-363
30. Soh CT, Lee KT, Im KI, Min DY, Ahn MH, Kim JJ, Tong TS (1985) Current status of malaria in Korea. Yonsei Rep Trop Med 16:11-18
31. Stowers AW, Cioce V, Shimp RL, Lawson M, Hui G, Muratova O, Kaslow DC, Robinson R, Long CA, Miller LH (2001) Efficacy of two alternative vaccines based on Plasmodium falciparum merozoite surface protein 1 in an Aotus challenge trial. Infect Immun 69:1536-1546
32. Vukovic P, Horgarth PM, Barnes N, Kaslow DC, Good MF (2000) Immunoglobulin G3 antibodies specific for the 19-kilodalton carboxyl-terminal fragment of Plasmodium yoelii merozoite surface protein 1 transfer protection to mice deficient in Fc-γRI receptors. Infect Immun 68:3019-3022